Financial News Feed

Stronger Sell Today ADMA ranks #5094 as SELL CANDIDATE. Weaker Sell
Today ADMA ranks #5094 as SELL CANDIDATE.

ADMA stock ADMA Biologics Inc

ADMA stock
ADMA Biologics Inc

Investors might be taking a closer look into the crystal ball to try and decipher what is in store for the second half of the year in the stock market. While cautious optimism may be the prevailing se...

Read more

Since ADMA Biologics Inc. (NASDAQ:ADMA) and Unity Biotechnology Inc. (NASDAQ:UBX) are part of the Biotechnology industry, they are influenced by contrast. The...

Read more

Seattle Genetics (NASDAQ:SGEN) and ADMA Biologics (NASDAQ:ADMA) are both medical companies, but which is the better stock? We will compare the two businesses based on the strength of their profitabili...

Read more

ADMA Biologics (NASDAQ:ADMA) and Seattle Genetics (NASDAQ:SGEN) are both medical companies, but which is the superior business? We will contrast the two companies based on the strength of their divide...

Read more

As Biotechnology companies, ADMA Biologics Inc. (NASDAQ:ADMA) and Y-mAbs Therapeutics Inc. (NASDAQ:YMAB) are our subject to contrast. And more specifically...

Read more

ADMA Biologics Inc. (NASDAQ:ADMA) and Tonix Pharmaceuticals Holding Corp. (NASDAQ:TNXP), both competing one another are Biotechnology companies. We will contrast their institutional ownership, analyst...

Read more

Wall Street analysts expect that ADMA Biologics Inc (NASDAQ:ADMA) will post $3.58 million in sales for the current fiscal quarter, according to Zacks Investment Research. Three analysts have provided ...

Read more

Shares of Adma Biologics (ADMA) have been trending lower over the past five bars, revealing bearish momentum for the shares, as they ran -17.04% for the week. Looking further out we note that the shar...

Read more

Among 5 analysts covering ADMA Biologics (NASDAQ:ADMA), 5 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. ADMA Biologics had 9 analyst reports since October 12, 2018 according to SRat...

Read more

ADMA Biologics Inc. (NASDAQ:ADMA) and GTx Inc. (NASDAQ:GTXI), are influenced by compare since they are both players in the Biotechnology. These factors are...

Read more

Both Aratana Therapeutics Inc. (NASDAQ:PETX) and ADMA Biologics Inc. (NASDAQ:ADMA) are each other’s competitor in the Biotechnology industry. Thus the compare of their profitability, analyst recomme...

Read more

Adverum Biotechnologies Inc. (NASDAQ:ADVM) and ADMA Biologics Inc. (NASDAQ:ADMA) compete with each other in the Biotechnology sector. We will analyze and compare their risk, analyst recommendations, p...

Read more

Looking back at some historical performance on shares of ADMA Biologics, Inc. (NASDAQ:ADMA), we can see that the stock price performance for the last week is -17.04%. Tracking back further over the pa...

Read more

Since Arcturus Therapeutics Ltd. (NASDAQ:ARCT) and ADMA Biologics Inc. (NASDAQ:ADMA) are part of the Biotechnology industry, they are influenced by compare....

Read more

Though short-term trading can be very lucrative, it can also be very risky. Short-term trading can last for only a few minutes or several days or weeks. Traders must understand the risks and the rewar...

Read more

News Feed powered by

Proudly made at

Rise Vilnius
in partnership with
Barclays Bank